Top Markets
#1 Black Phoenix Black Phoenix +324.80%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +57.52%
#4 Gold Park Gold Park +55.04%
#5 Acurast Acurast +30.18%
#6 BasedHype BasedHype +28.28%
#7 Cryptopia Cryptopia +22.67%
#8 Avantis Avantis +19.62%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.72%
#10 MYX Finance MYX Finance +16.77%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rang in aandelen #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Aandeelprijs
$0.0202
Laatst gesynchroniseerd: 2024-11-19
Marktkapitalisatie
$44.67K
Verandering (1 dag)
-0.49%
Verandering (1 jaar)
0.00%
Land
IL
Handel Notable Labs, Ltd. (NTBL)

Categorie

Healthcare
P/S-ratio voor Notable Labs, Ltd. (NTBL)
P/S-ratio op August 2026 TTM: 7.72
Volgens de meest recente financiële rapporten en aandelenkoers van Notable Labs, Ltd. is de huidige P/S-ratio (TTM) 7.72. Eind 2022 had het bedrijf een P/S-ratio van 1.16K.
P/S-ratiohistoriek voor Notable Labs, Ltd. van 2015 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
2026 (TTM) 7.72 -41.88%
2023 13.29 -98.86%
2022 1.16K -93.42%
2021 17.67K 387.47%
2020 3.63K -4.00%
2019 3.78K 97.37%
2018 1.91K 289.61%
2017 491.09 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 27.92%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 33.38%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -35.54%
BE